Herb Baer named chief marketing officer of Water-Jel
CARLSTADT, N.J. Water-Jel Technologies last week named Herb Baer its new chief marketing officer and vice president, consumer sales, the company announced Friday.
“We created this new position to help drive the growth we foresee in both existing and new channels,” stated Water-Jel president Michael Pisani. “Baer’s new goals are to set the direction for Water-Jel’s go-to-market strategies, increase brand and product awareness and develop and market new products through the industrial and retail channels.”
Water-Jel Technologies provides Emergency Medical Services, Industrial Safety professionals and the United States Military with emergency first aid burn care products. In addition to the company’s burn care line, Water-Jel markets WATER-JEL Burn Jel Plus and other burn products as well as Kidz Health Children’s Adhesive Bandages, and licensed character personal toiletry products to consumers through a variety of drug and national discount stores.
Baer has two decades of experience with Fuji Photo Film USA, where he held vice-president level marketing and sales roles across a wide section of channels.
Baer earned his Bachelors degree in Economics and Human Kinetics from Rutgers University and his Masters degree in Sports Management from Adelphi University.
FDA responds to WHO’s query on ten medications
ROCKVILLE, Md. The Food and Drug Administration last week requested comments concerning abuse potential, actual abuse, medical usefulness, trafficking, and impact of scheduling changes on availability for medical use of 10 drugs, including the over-the-counter cough suppressant dextromethorphan. The information will be utilized by FDA in its preparation of the United States’ response to a World Health Organization query.
Dextromethorphan is the only OTC medicine on WHO’s list. The other medicines being examined include:
- Gamma-hydroxybutyric acid, a narcolepsy drug marketed in the United States under the brand name Xyrem (Jazz Pharmaceuticals) and controlled under Schedule III status (drugs with recognized medical use with a moderate to low incidence of dependence);
- the anesthetic ketamine, controlled under Schedule III status;
- benzylpiperazine, an illegal drug in the United States;
- trifluoromethylphenylpiperazine, not marketed in the United States;
- meta-chlorophenylpiperazine, not marketed in the United States;
- methoxyphenylpiperazine, not marketed in the United States;
- methylenedioxybenzylpiperazine, not marketed in the United States;
- the reagent gamma-butyrolactone, not marketed in the United States, but controlled as a list I chemical ; and
- the solvent butanediol (a scheduled substance in some states but not nationally).
WHO has called for information on these drugs to ascertain whether or not the organization should recommend that certain international restrictions be placed on distribution of the medicines.
Comments submitted to FDA are due Oct. 6. WHO meets April 20-23, 2009, to discuss the issue.
LifeScan unveils new colors for glucose monitors
MILPITAS, Calif. LifeScan on Friday introduced two new colors for its line of OneTouch UltraMini Meters—purple twilight and blue comet.
The two new colors were included in response to consumer preferences. During the 2007 “What’s Your Color?” Giveaway, an online sweepstakes in which 10,000 winners received a OneTouch UltraMini Meter in the color of their choice, entrants were also asked to vote for their favorite future color offerings, and purple topped the list.
In subsequent customer feedback and market research, LifeScan also found that purple was the top requested color among women and blue was the overall most-requested color among both men and women.
“By providing people with product choices that reflect their individual taste and sense of style, we hope to help make glucose monitoring feel a little less clinical and a lot more personal,” stated Kim Mullarkey, LifeScan vice president of U.S. marketing.
Since the introduction of colors in 2007, the OneTouch UltraMini Meter has become the No. 1 selling blood glucose monitor nationwide, the company stated.